Skip to main content
Clinical Trials/ACTRN12611000328976
ACTRN12611000328976
Not yet recruiting
未知

uclear Perfusion Tomography for the Assessment of the Pulmonary Circulation

David Celermajer0 sites36 target enrollmentMarch 28, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
David Celermajer
Enrollment
36
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 28, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
David Celermajer

Eligibility Criteria

Inclusion Criteria

  • 1\. Control group
  • \- No history of cardiac or respiratory disease
  • \- Normal spirometry
  • \- Normal transthoracic echocardiogram
  • \- Smoking history \< 10 years
  • \- No risk factor for pulmonary hypertension
  • 2\. High Risk for PAH Group
  • \- History of scleroderma or carrier of BMPR2 mutation
  • \- Normal resting pulmonary artery pressure
  • \- No significant lung disease

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials